Skip to main content

Angiotensin II Receptor Blockers and Celiac Disease

Basic Details
Date Posted
Status
Complete
Medical Product
angiotensin II receptor blocker (ARB)
candesartan
eprosartan
irbesartan
losartan
olmesartan
telmisartan
valsartan
Health Outcome(s)
celiac disease
Description

Modular program-based one-time assessment of the risk of celiac disease associated with new use of angiotensin II receptor blockers (ARBs). Modular programs are adaptable standardized programs.

Deliverables (1)
Mini-Sentinel Angiotensin II Receptor Blockers and Celiac Disease
Additional Details
FDA Center
CDER
Analysis Type
Mini-Sentinel
Data Sources
Mini-Sentinel Distributed Dataset (MSDD)